Quinine and severe falciparum malaria in late pregnancy

Lancet. 1985 Jul 6;2(8445):4-8. doi: 10.1016/s0140-6736(85)90056-x.

Abstract

Quinine dihydrochloride was given intravenously to 12 women with severe falciparum malaria in the third trimester of pregnancy. The initial dose consisted of 10 or 20 mg salt/kg over 4 h and was followed by 10 mg salt/kg every 8 h until patients were fit to swallow, when quinine sulphate tablets were given. Uterine activity showed little or no change despite rising quinine concentrations. Of 3 patients in labour, 2 proceeded normally while a third had a successful caesarean section for fetal distress. Late (type II) decelerations of the fetal heart rate were recorded in 6 patients before treatment but in most patients signs of fetal distress diminished as the maternal temperature fell. Hypoglycaemia and hyperinsulinaemia developed in 7 patients, in 2 before quinine was started. The important toxic effect of quinine in late pregnancy is not an oxytocic action but rather its capacity to release insulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Glucose / analysis
  • Female
  • Fetus / drug effects
  • Humans
  • Insulin / blood
  • Labor, Obstetric / drug effects
  • Malaria / blood
  • Malaria / drug therapy*
  • Plasmodium falciparum
  • Pregnancy
  • Pregnancy Complications, Infectious / blood
  • Pregnancy Complications, Infectious / drug therapy*
  • Quinine / adverse effects
  • Quinine / blood
  • Quinine / therapeutic use*

Substances

  • Blood Glucose
  • Insulin
  • Quinine